BR0112734A - Agente terapêutico cristalino - Google Patents
Agente terapêutico cristalinoInfo
- Publication number
- BR0112734A BR0112734A BR0112734-9A BR0112734A BR0112734A BR 0112734 A BR0112734 A BR 0112734A BR 0112734 A BR0112734 A BR 0112734A BR 0112734 A BR0112734 A BR 0112734A
- Authority
- BR
- Brazil
- Prior art keywords
- therapeutic agent
- crystalline therapeutic
- crystalline
- pyridylsulfonyl
- ethylpiperazine
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940124597 therapeutic agent Drugs 0.000 title abstract 2
- YPFZMBHKIVDSNR-UHFFFAOYSA-N 5-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylpyridin-3-yl]-3-ethyl-2-(2-methoxyethyl)-4h-pyrazolo[4,3-d]pyrimidin-7-one Chemical compound C1=C(C=2NC(=O)C3=NN(CCOC)C(CC)=C3N=2)C(OCC)=NC=C1S(=O)(=O)N1CCN(CC)CC1 YPFZMBHKIVDSNR-UHFFFAOYSA-N 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0018656A GB0018656D0 (en) | 2000-07-28 | 2000-07-28 | Pharmaceutically active compounds |
| GB0106464A GB0106464D0 (en) | 2001-03-15 | 2001-03-15 | Crystalline therapeutic agent |
| PCT/IB2001/001280 WO2002010171A1 (en) | 2000-07-28 | 2001-07-18 | Crystalline therapeutic agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0112734A true BR0112734A (pt) | 2004-08-10 |
Family
ID=26244756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0112734-9A BR0112734A (pt) | 2000-07-28 | 2001-07-18 | Agente terapêutico cristalino |
Country Status (45)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004072079A1 (en) * | 2003-02-11 | 2004-08-26 | Pfizer Limited | Hydrated and anhydrous sildenafil hemi-citrate compound |
| EA008596B1 (ru) | 2003-04-29 | 2007-06-29 | Пфайзер Инк. | 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ |
| US7572799B2 (en) | 2003-11-24 | 2009-08-11 | Pfizer Inc | Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
| DE602005011784D1 (de) | 2004-04-07 | 2009-01-29 | Pfizer | Pyrazoloä4,3-düpyrimidine |
| BRPI0609225A2 (pt) * | 2005-05-12 | 2010-03-09 | Pfizer | formas cristalinas anidras de n-[1-(2-etoxietil)-5-(n-etil-n-metilamino)-7-(4-metilpiridi n-2-il-amino)-1h-pirazolo[4,3-d]pirimidina-3-carbonil] metanossulfonamida, composição farmacêutica compreendendo as mesmas e uso das mesmas |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20000712A2 (en) * | 1998-04-20 | 2001-06-30 | Pfizer | PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| TWI265925B (en) * | 1999-10-11 | 2006-11-11 | Pfizer | Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them |
-
2001
- 2001-07-18 ES ES01951842T patent/ES2231521T3/es not_active Expired - Lifetime
- 2001-07-18 JP JP2002515900A patent/JP2004505087A/ja active Pending
- 2001-07-18 MX MXPA03000856 patent/MX233602B/es active IP Right Grant
- 2001-07-18 DE DE60108398T patent/DE60108398T2/de not_active Expired - Fee Related
- 2001-07-18 CN CNB018133924A patent/CN1207297C/zh not_active Expired - Fee Related
- 2001-07-18 HU HU0302982A patent/HUP0302982A3/hu unknown
- 2001-07-18 EP EP01951842A patent/EP1305314B1/en not_active Expired - Lifetime
- 2001-07-18 HR HR20030061A patent/HRP20030061A2/hr not_active Application Discontinuation
- 2001-07-18 KR KR20037001202A patent/KR100457937B1/ko not_active Expired - Fee Related
- 2001-07-18 EA EA200300079A patent/EA004681B1/ru not_active IP Right Cessation
- 2001-07-18 AU AU7269001A patent/AU7269001A/xx active Pending
- 2001-07-18 NZ NZ523226A patent/NZ523226A/en unknown
- 2001-07-18 EE EEP200300045A patent/EE200300045A/xx unknown
- 2001-07-18 CZ CZ2003126A patent/CZ2003126A3/cs unknown
- 2001-07-18 WO PCT/IB2001/001280 patent/WO2002010171A1/en not_active Ceased
- 2001-07-18 CA CA002417264A patent/CA2417264C/en not_active Expired - Fee Related
- 2001-07-18 GE GE5062A patent/GEP20053494B/en unknown
- 2001-07-18 SK SK57-2003A patent/SK572003A3/sk not_active Application Discontinuation
- 2001-07-18 IL IL15322601A patent/IL153226A0/xx not_active IP Right Cessation
- 2001-07-18 BR BR0112734-9A patent/BR0112734A/pt not_active IP Right Cessation
- 2001-07-18 PL PL01365133A patent/PL365133A1/xx unknown
- 2001-07-18 UA UA2003010715A patent/UA72631C2/uk unknown
- 2001-07-18 OA OA1200300008A patent/OA12337A/fr unknown
- 2001-07-18 DZ DZ013364A patent/DZ3364A1/xx active
- 2001-07-18 YU YU4703A patent/YU4703A/sh unknown
- 2001-07-18 AT AT01951842T patent/ATE286901T1/de not_active IP Right Cessation
- 2001-07-18 PT PT01951842T patent/PT1305314E/pt unknown
- 2001-07-18 AU AU2001272690A patent/AU2001272690B2/en not_active Ceased
- 2001-07-24 PE PE2001000746A patent/PE20020277A1/es not_active Application Discontinuation
- 2001-07-25 MY MYPI20013530A patent/MY117831A/en unknown
- 2001-07-26 AP APAP/P/2001/002234A patent/AP1400A/en active
- 2001-07-26 PH PH12001001922A patent/PH12001001922B1/en unknown
- 2001-07-26 UY UY26854A patent/UY26854A1/es not_active Application Discontinuation
- 2001-07-26 DO DO2001000217A patent/DOP2001000217A/es unknown
- 2001-07-26 AR ARP010103576A patent/AR032628A1/es unknown
- 2001-07-27 SV SV2001000570A patent/SV2001000570A/es not_active Application Discontinuation
- 2001-07-27 TW TW090118441A patent/TWI285643B/zh not_active IP Right Cessation
- 2001-07-27 PA PA20018523501A patent/PA8523501A1/es unknown
- 2001-07-27 TN TNTNSN01112A patent/TNSN01112A1/fr unknown
-
2002
- 2002-11-12 BG BG107266A patent/BG107266A/bg unknown
- 2002-11-18 IS IS6626A patent/IS6626A/is unknown
- 2002-11-20 IN IN1649MU2002 patent/IN2002MU01649A/en unknown
-
2003
- 2003-01-20 MA MA27003A patent/MA26931A1/fr unknown
- 2003-01-27 NO NO20030416A patent/NO324220B1/no unknown
- 2003-01-28 EC EC2003004454A patent/ECSP034454A/es unknown
- 2003-02-24 ZA ZA200301457A patent/ZA200301457B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03006093A (es) | Derivados de n(fenilsulfonil)glicina y su uso terapeutico. | |
| TR200101499T1 (tr) | Azepinoindol türevleri, hazırlanmaları ve kullanımları. | |
| DE60236102D1 (en) | 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren | |
| BR0208338A (pt) | Derivados de piridina | |
| SE9704544D0 (sv) | Novel compounds | |
| NO985643L (no) | Antimikrobielle blandinger | |
| DK1036058T3 (da) | Adamantanderivater | |
| MY135233A (en) | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials | |
| MXPA03000510A (es) | Sales estables de acido o-acetilsalicilico con aminoacidos basicos. | |
| AU2001282399A1 (en) | Resorcinol derivatives | |
| DK0695171T3 (da) | Lyosfærer indeholdende gonadotropin | |
| MX9503529A (es) | Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen. | |
| MXPA04001256A (es) | Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso. | |
| SE9802208D0 (sv) | Novel compounds | |
| EA200001010A1 (ru) | Применение дексмедетомидина для седативного воздействия в отделении интенсивной терапии | |
| BR0112734A (pt) | Agente terapêutico cristalino | |
| SE9802209D0 (sv) | Novel compounds | |
| WO2002057246A3 (en) | Inhibitors of cruzipain and other cysteine proteases | |
| MXPA04000272A (es) | Derivados de 4-aminociclohexanol sustituidos. | |
| ZA983231B (en) | Substituted benzyloxyimino compounds. | |
| PY0117546A (es) | Agente terapeutico cristalino | |
| BR0212289A (pt) | Anticorpos contra caspase-8, preparação e uso do mesmo | |
| GR1004434B (el) | Χρησηατουαdiclofenacαhααποδεκτωνααλατωνααυτουαγιαατηνααντιμετωπισηατωναεγκαυματων | |
| KR960700053A (ko) | 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer) | |
| SE9803277D0 (sv) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A, 9A E 10A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011. |